Genome & Company Revenue

Genome & Company had revenue of 6.56B KRW in the quarter ending September 30, 2025, with 41.86% growth. This brings the company's revenue in the last twelve months to 25.95B, up 7.74% year-over-year. In the year 2024, Genome & Company had annual revenue of 27.74B with 94.07% growth.

Revenue (ttm)

25.95B

Revenue Growth

+7.74%

P/S Ratio

10.12

Revenue / Employee

n/a

Employees

n/a

Market Cap

262.77B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.74B	13.45B	94.07%
Dec 31, 2023	14.30B	211.39M	1.50%
Dec 31, 2022	14.08B	13.63B	3,021.27%
Dec 31, 2021	451.25M	300.66M	199.67%
Dec 31, 2020	150.58M	104.75M	228.54%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
GC Cell	170.13B
ISU Abxis	66.39B
NIBEC	32.96B
S.Biomedics	16.96B
Prestige Biologics	13.36B
QuadMedicine	13.11B
Kangstem Biotech	12.77B
Y-Biologics	3.61B

Revenue Rankings